Titre : | Psychedelic-assisted group therapy: A systematic review (2019) |
Auteurs : | A. TROPE ; B. T. ANDERSON ; A. R. HOOKER ; G. GLICK ; C. STAUFFER ; J. D. WOOLLEY |
Type de document : | Article : Périodique |
Dans : | Journal of Psychoactive Drugs (Vol.51, n°2, April-June 2019) |
Article en page(s) : | 174-188 |
Langues: | Anglais |
Discipline : | TRA (Traitement et prise en charge / Treatment and care) |
Mots-clés : |
Thésaurus mots-clés THERAPIE DE GROUPE ; USAGE THERAPEUTIQUE ; HALLUCINOGENES ; LSD ; PSILOCYBINE ; DEPENDANCE ; NEVROSE |
Résumé : | Contemporary research with classic psychedelic drugs (e.g., lysergic acid diethylamide (LSD) and psilocybin) is indebted to the twentieth-century researchers and clinicians who generated valuable clinical knowledge of these substances through experimentation. Several recent reviews that highlight the contributions of this early literature have focused on psychedelic-assisted individual psychotherapy modalities. None have attempted to systematically identify and compile experimental studies of psychedelic-assisted group therapy. In therapeutic settings, psychedelics were often used to enhance group therapy for a variety of populations and clinical indications. We report on the results of a systematic review of the published literature in English and Spanish on psychedelic-assisted group therapies. Publications are characterized by their clinical approach, experimental method, and clinical outcomes. Given the renewed interest in the clinical use of psychedelic medicines, this review aims to stimulate hypotheses to be tested in future research on psychedelic-assisted psychotherapy, group process, and interpersonal functioning. |
Domaine : | Drogues illicites / Illicit drugs |
Sous-type de document : | Revue de la littérature / Literature review |
Affiliation : | Department of Psychiatry, Weill Institute for Neurosciences, UCSF, San Francisco, CA, USA |
Cote : | Abonnement |
Accueil